All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
2 warning events since 2017; the latest 2022-11-15.
From the record
Marchex, Inc.'s filings since 2017 show 2 warning events: an auditor change (8-K item 4.01, 2 times, the latest 2022-11-15) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
-8.2% a year over 9 filed years; profitable in 0 of 9.
From the record
Marchex, Inc.'s 9 filed years say what it did: revenue went from $90 million in fiscal 2017 to $45 million in fiscal 2025, down 8.2% a year; it rose in 1 of 8 years; the deepest fall was 50% from fiscal 2017 to fiscal 2025; net income was positive in 0 of 9 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
SI estimate 5.6/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Marchex, Inc.'s shareholder treatment is put at 5.6 of 10 with a confidence of 20 of 100, because fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income, so the desk assumes the typical reading of its industry family, the median of 180 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
What are they doing right now?
Is it financially healthy right now?
ROE -17%: lost 17¢ per shareholder dollar. Leverage 24%: owes 24¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-12-31, Marchex, Inc. lost about 17 cents for every dollar of shareholders' money, and gross profitability: its products earned about 73 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 24 cents per dollar of assets (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
bottom 26% of 218 in its family; net margin -11.5%.
From the record
Marchex, Inc.'s standing among 218 graded names in its industry family: revenue of $45 million in fiscal 2025 ranks in the bottom 25% by size; a net margin of -11.5% ranks in the bottom 38%; revenue growth of -4.5% a year over the last 3 filed years ranks in the bottom 15% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
bottom 43% of 139 in its family for leadership.
From the record
Marchex, Inc.'s leadership, from its insiders' filings and its current reports: no one files under a chief executive's title, so that part is not read; the 9 officers and directors filing in the last fifteen months have been on the record a median of 7.6 years (top 18%); 12 officer or director changes were reported on Form 8-K since 2023-11-13, against the 9 people in charge now (bottom 5%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they set up to do next?
How much room does it have to grow?
bottom 48% of 216 in its family for room to expand.
From the record
Marchex, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $10 million against no long-term debt tagged leaves 25.1% of its assets as net cash, top 27% of its family; cash from operations less capital spending is -3.2% of revenue (bottom 28%); a gross margin of 63.4% (bottom 39%); research spending of 21.5% of revenue (top 48%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
bottom 29% of 213 in its family for growth drivers.
From the record
Marchex, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -4.5% a year over the last three filed years against -8.2% over all 9, speeding up (top 8% of its family); the newest year grew -5.6% (bottom 12%); research spending grew -12.1% a year (bottom 12%); capital spending grew -76.7% a year (bottom 2%) (its annual reports). Marchex, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
bottom 44% of 194 in its family for expectations against reality.
From the record
Marchex, Inc.'s newest year against its own record: revenue of $45 million in fiscal 2025 came in 1.7% below the $46 million its prior three years' pace pointed to (bottom 46% of its family); net income of $5 million against a prior three-year average of $8 million (bottom 45%); a net margin of -11.5% against -15.3% before (bottom 40%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made